We are excited to welcome John Klish (Klishy) as a guest speaker at the Testicular Cancer Conference 2018. John Klish was born with bi-lateral profound hearing loss, meaning profoundly deaf. That didn’t stop him from following his dreams. He graduated from Colorado State University with a degree in mechanical engineering while racing on the collegiate cycling team.
We are excited to welcome Tom Willner as a guest speaker at the Testicular Cancer Conference 2018. Tom Willner, President of Tom Willner Music and co-founder of Center Stage Education, is a musician, published songwriter, playwright, speaker, and author. He is a testicular cancer survivor who has written a musical and a book about his experience that raise awareness and funding for cancer charities, and teach healthcare professionals about the patient experience.
We are excited to welcome back Dr. Lawrence Einhorn as our honorary guest speaker, world renowned tc medical expert at our Testicular Cancer Conference 2018. Lawrence Einhorn, MD, has been on the IU School of Medicine Department of Medicine faculty since 1973. His field of expertise includes clinical trials and supportive care, with focus in the areas of lung and testicular cancers. Dr. Einhorn has also been involved in the clinical development of new drug therapies. Studies chaired by Dr. Einhorn at IU School of Medicine in testicular cancer led to the FDA approval of cisplatin, etoposide and ifosfamide. In addition, his groups conducted the pivotal studies that led to the approval of both gemcitabine and pemetrexed in non-small cell lung cancer. Dr. Einhorn’s studies helped to save many lives turning testicular cancer into a highly curable cancer with a 90% overall survival rate.
We are excited and honored to welcome back Dr. Ajay K. Nangia as a guest speaker at the Testicular Cancer Conference 2018. Dr. Ajay K. Nangia is Professor and Vice-Chair of Urology at the University of Kansas Medical Center. Dr. Nangia received his medical degree from St. Thomas and Guy's Hospital Medical School in London, U.K. He completed two years of research at Yale University prior to residency. He completed his Urology residency at the University of Pittsburgh Medical Center and a Male Infertility and Microsurgery fellowship at the Cleveland Clinic Foundation in Cleveland, Ohio. Dr. Nangia was at Dartmouth-Hitchcock Medical Center in New Hampshire prior to coming to Kansas. Dr. Nangia is a fellowship trained male infertility specialist in the metropolitan Kansas City area with 18 years of experience and national involvement in the field. He is one of the leading male infertility specialists nationally. He has extensive experience in male infertility, urological microsurgical reconstruction, including vasectomy reversals in the Kansas, Western Missouri, Oklahoma and Nebraska region. He also specializes in Men's Health issues as they relate to sexual and reproductive health, especially male contraception, testosterone deficiency, erectile dysfunction and ejaculatory problems. He and Dr. Broghammer have one of the largest practices in surgical correction for erectile dysfunction (penile prostheses) in the region. He also specializes in fertility and sexual dysfunction issues related to spinal cord injuries and pre- and post-cancer treatment. Dr. Nangia is a leading national specialist in the field of male infertility, vasectomy reversals, vasectomies and complications from vasectomies. He also has a secondary specialty in stone disease.
We are excited and honored to welcome back Dr. Phillip Pierorazio as a guest speaker at the Testicular Cancer Conference 2018. Dr. Phillip Pierorazio is an Assistant Professor of Urology and Oncology in the Brady Urological Institute at Johns Hopkins University. Dr. Pierorazio is originally from New York, received his undergraduate degree from Georgetown University in Washington, DC and his medical degree from Columbia University, College of Physicians & Surgeons in New York City where he completed a Doris Duke Clinical Research Fellowship in Urologic Oncology.
We are excited and honored to welcome back Dr. Nicholas Cost as a guest speaker at the Testicular Cancer Conference 2018. Dr. Nicholas Cost is a assistant professor, surgery-urology at University of Colorado Anschutz Medical Campus. Dr. Cost’s interest in testicular cancer has guided his training and career development. Testicular cancer is a disease that affects boys and men of all ages. For that reason, after completing his residency in Urology and Urologic Surgery, he pursued fellowship training in both urologic oncology (cancer treatment) and pediatric urology. This allows him to provide care to children, adolescents, and adults with testicular cancer at both “adult” and “pediatric” hospitals. I am involved with testicular cancer both as a clinician and as a researcher. My particular areas of focus include: Robotic surgery for testicular cancer, testicular cancer in adolescents and the Long-term effects of testicular-cancer treatment. Dr. Cost’s additional clinical interests are in cancers and tumors in children, adolescents, and adults. Specifically kidney tumors (Wilms Tumor, Renal Cell Carcinoma (RCC), Angiomyolipomas(AML)), Testicular and Para-testicular tumors, and Pelvic Tumors (Rhabdomyosarcomas). This additionally includes patients with tumor predisposition syndromes such as von Hippel Lindau, Tuberous Sclerosis, and Birt-Hogg-Dube. His training in both urologic oncology and pediatric urology has prepared me to care for these patients of all ages and can see them either through Children's Hospital Colorado or through the University Hospital. Dr. Cost is also interested in the use of minimally invasive surgery (robotic-assisted laparoscopy, laparoscopy, single-site laparoscopy, and endoscopy) for all variety of urologic conditions. Within other areas of Pediatric Urology, he is interested in Ureteropelvic junction obstruction, Vesicoureteral reflux, and Urolithiasis (kidney stones).
I was a prisoner of my past. My prison warden was someone called “I used to”. “I used to” would remind me of my previous accomplishments lifting humongous weights, running long distances, and various feats of acrobatics. The warden was quick to steal the joy out of my life and pull the rug out from under me whenever I attempted to regain the strength I was so proud of having before. I spent many days feeling sorry for myself and lamenting the things I could no longer do until one day I decided I was done with the suffering.
Hi guys! My name is Jason Greenspan and I'll be a five-year Testicular Cancer survivor in November 2017. In May 2012, I was a very healthy 18-year-old and in my senior year of high school. I already applied to colleges and was excited to attend my senior prom. A week before my prom, I was watching television and had a simple itch. That itch ended up being the most important itch of my entire life. I noticed something hard; something I hadn’t noticed before. I went to the doctors a few days later and he said the words I never thought I would hear; “YOU HAVE CANCER.” When the doctor said those words, my world stopped. The only thing I could think of is what my future would be like. I was diagnosed with Stage IIA Testicular Cancer.